🇺🇸 FDA
Patent

US 8518968

Hydrazone and diacyl hydrazine compounds and methods of use

granted A61PA61P17/00A61P19/02

Quick answer

US patent 8518968 (Hydrazone and diacyl hydrazine compounds and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P17/00, A61P19/02, A61P25/28, A61P27/02